This compansy' shares have crashed 77 percent YTD. Consolidation may offer a new entry opportunity for this restructuring drug company. It is highly unlikely to go bankrupt. The drug company reaffirmed its revenue guidance as part of its 2nd quarter earnings release, and guided for significant debt reductions on the back of asset sales and free cash flow. Further, its new Chief Executive Officer put $8 billion of non core asset sales on the table in order to pay down the drug company's debt.
Drug company Valeant Pharmaceuticals International, Inc. (NYSE:VRX) was the most exciting story in the stock market of 2015/6 if you ask me. Unfortunately, shareholders of Valeant Pharmaceuticals that bought into the acquisition model a year ago are now sitting on devastating losses. I can only say congrats to all those investors that jumped off the sinking ship in time last year, and those investors that actually shorted the drug company.
Source: Seeking Alpha
Related Articles:
- 7 Undervalued, Big-Name Stocks To Consider For Your Dividend Portfolio
- 7 High-Yield Energy Stocks Growing Their Dividends
- 5 Dividend Stocks In Need Of A Market Correction
- 10 Dividend Stocks Building A Growing Cash Stream
- How To Build A Sustainable High Yield Portfolio
________________________________________________________________
Subscribe to:
Post Comments (Atom)
Popular Posts Last 30 Days
-
The fact is that there are many interesting high-yielding companies that have good long-term prospects. Besides, as the markets get more vol...
-
Dividend stocks are very appealing to investors, for good reason. Growth stocks tend to make the headlines — with the 2020 pandemic, shareho...
-
Part of the joy of investing is seeing your good investments continue to grow, years after your initial purchase. Aside from the financial s...
-
A common measure of dividend sustainability is the payout ratio, the percent of earnings that are paid out to shareholders. Unfortunately, e...
-
Investors looking for the best dividend stocks for 2021 and beyond should take a closer look at the stocks with the longest histories of ann...
-
Some investors — usually referred to as income investors — specifically set out to buy securities that pay them even before stock price appr...
-
A lot changes when you shift from working to retirement, including how you invest. Most investors switch from building a nest egg to living ...
-
Are you looking for a great dividend stock to add to your portfolio? There are many options out there, but the reality is that many just don...
-
Last month we wrote about the top four companies in our model portfolio in the article 4 Dividend Dominators for 2021 - Companies With More ...
-
This stock yields 7.07% and pays monthly. It's selling at a -6.4% discount to NAV - much deeper than its three- and five-year average di...
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.